Under pressure, Gilead expands Sovaldi licensing deal to four middle-income countries

Media Article 24 Aug 2017

I-MAK co-director and co-founder Tahir Amin offers his take on Gilead’s voluntary licensing deals— “Gilead didn’t do this because it wanted to.”

Partner with us now to build
a more just and equitable
medicine system for all.